330 related articles for article (PubMed ID: 15247123)
1. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
Anderson WF; Chu KC; Chang S; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
[TBL] [Abstract][Full Text] [Related]
2. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
3. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
Li CI; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
Anderson WF; Chu KC; Chang S
J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
[TBL] [Abstract][Full Text] [Related]
5. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
Anderson WF; Pfeiffer RM; Dores GM; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1899-905. PubMed ID: 17035397
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
7. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
[TBL] [Abstract][Full Text] [Related]
8. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
[TBL] [Abstract][Full Text] [Related]
9. Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications.
Anderson WF; Chu KC; Devesa SS
Breast Cancer Res Treat; 2004 Nov; 88(2):149-59. PubMed ID: 15564798
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
11. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years.
Li CI; Moe RE; Daling JR
Arch Intern Med; 2003 Oct; 163(18):2149-53. PubMed ID: 14557212
[TBL] [Abstract][Full Text] [Related]
12. Decline in breast cancer incidence--United States, 1999-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):549-53. PubMed ID: 17557070
[TBL] [Abstract][Full Text] [Related]
13. Is male breast cancer similar or different than female breast cancer?
Anderson WF; Althuis MD; Brinton LA; Devesa SS
Breast Cancer Res Treat; 2004 Jan; 83(1):77-86. PubMed ID: 14997057
[TBL] [Abstract][Full Text] [Related]
14. Regional differences in the incidence and treatment of carcinoma in situ of the breast.
Choi WS; Parker BA; Pierce JP; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):317-20. PubMed ID: 8722225
[TBL] [Abstract][Full Text] [Related]
15. Regional variations in breast cancer incidence among California women, 1988-1997.
Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
[TBL] [Abstract][Full Text] [Related]
16. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
17. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor status of breast cancer in Ontario.
McKeown-Eyssen GE; Rogers-Melamed I; Clarke EA
CMAJ; 1985 Nov; 133(10):997-1000. PubMed ID: 4063915
[TBL] [Abstract][Full Text] [Related]
20. Geographic excess of estrogen receptor-positive breast cancer.
Benz CC; Clarke CA; Moore DH
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1523-7. PubMed ID: 14693747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
